The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
Open accessAbstract
Regulation of transcription factor Nrf2 (NF-E2-related factor 2) involves redox-sensitive proteasomal degradation via the E3 ubiquitin ligase Keap1/Cul3. However, Nrf2 is controlled by other mechanisms that have not yet been elucidated. We now show that glycogen synthase kinase 3 (GSK-3) phosphorylates a group of Ser residues in the Neh6 domain of mouse Nrf2 that overlap with an SCF/β-TrCP destruction motif (DSGIS, residues 334 to 338) and promotes its degradation in a Keap1-independent manner. Nrf2 was stabilized by GSK-3 inhibitors in Keap1-null mouse embryo fibroblasts. Similarly, an Nrf2(ΔETGE) mutant, which cannot be degraded via Keap1, accumulated when GSK-3 activity was blocked. Phosphorylation of a Ser cluster in the Neh6 domain of Nrf2 stimulated its degradation because a mutant Nrf2(ΔETGE 6S/6A) protein, lacking these Ser residues, exhibited a longer half-life than Nrf2(ΔETGE). Moreover, Nrf2(ΔETGE 6S/6A) was insensitive to β-TrCP regulation and exhibited lower levels of ubiquitination than Nrf2(ΔETGE). GSK-3β enhanced ubiquitination of Nrf2(ΔETGE) but not that of Nrf2(ΔETGE 6S/6A). The Nrf2(ΔETGE) protein but not Nrf2(ΔETGE 6S/6A) coimmunoprecipitated with β-TrCP, and this association was enhanced by GSK-3β. Our results show for the first time that Nrf2 is targeted by GSK-3 for SCF/β-TrCP-dependent degradation. We propose a "dual degradation" model to describe the regulation of Nrf2 under different pathophysiological conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Neh6 domain is a redox-insensitive degron that provides Keap1-independent negative Nrf2 regulation. Similar to Neh2, Neh6 contains two highly conserved 334DSGIS338 and 373DSAPGS378 motifs to which the β-transducin repeat-containing protein (βTrCP) binds, and within the DSGIS motif, a phosphorylation site for glycogen synthase kinase-3 (GSK3) that enhances βTrCP activity upon GSK3-mediated ph”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [62]
Citations
Cites
1 retracted
Phosphorylation of Tyrosine 568 Controls Nuclear Export of Nrf2
Jain, A. K., & Jaiswal, A. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511198200 · Cited by 171
Retractedβ‐catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,586
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,284
Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J., & Harper, J. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80403-1 · Cited by 1,233
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival
Cullinan, S. B., Zhang, D. D., Hannink, M., Arvisais, E. W., Kaufman, R. J., & Diehl, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7198-7209.2003 · Cited by 1,233
Cited by
Sorted by citations
Items 301–400 of 768
Shehata, M. K., Ismail, A. A., & Kamel, M. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417928 · Cited by 55
NRF2-targeted therapeutics: New targets and modes of NRF2 regulation
de la Vega, M. R., Dodson, M. B., Chapman, E., & Zhang, D. D. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.005 · Cited by 55
Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
Ranea‐Robles, P., Launay, N., Ruíz, M., Calingasan, N. Y., Dumont, M., Naudí, A., Portero‐Otín, M., Pamplona, R., Ferrer, I., Beal, M. F., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708604 · Cited by 55
Zhang, H.-F., Wang, J., Wang, Y., Gao, C. H., Gu, Y.-T., Huang, J., Wang, J., & Zhang, Z. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2853534 · Cited by 55
Nrf2 as a potential target for Parkinson’s disease therapy
Niu, Y., Zhang, J., & Dong, M. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02071-5 · Cited by 54
Park, J.-Y., Kim, S., Sohn, H., Koh, Y. H., & Jo, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-50877-8 · Cited by 53
Hsu, W., Wang, C.-M., Yao, C., Chen, S., Nien, C.-Y., Sun, Y.-H., Tseng, T.-Y., & Luo, Y.-H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05512-2 · Cited by 58
The naked mole-rat as an animal model in biomedical research: current perspectives
Smith, E. S. J., Schuhmacher, L.-N., & Husson, Z. (2015) · Open Access Animal Physiology · doi:10.2147/oaap.s50376 · Cited by 26
Pantoja, I. E. M., Hu, C., Perrone‐Bizzozero, N. I., Zheng, J., & Bizzozero, O. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13837 · Cited by 55
IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model
Kitamura, H., Onodera, Y., Murakami, S., Suzuki, T., & Motohashi, H. (2017) · Oncogene · doi:10.1038/onc.2017.236 · Cited by 54
Binding partners of NRF2: Functions and regulatory mechanisms
Nam, L. B., & Keum, Y. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108184 · Cited by 55
Huang, S., He, T., Yang, S., Sheng, H., Tang, X., Bao, F., Wang, Y., Lin, X., Yu, W., Cheng, F., et al. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1072 · Cited by 54
Wang, Y., Gong, F., Qi, X., Zheng, Y., Zheng, X.-T., Chen, Y., Yang, Z., Qing-Ye, Mao, E., & Chen, E. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2405943 · Cited by 54
Degrons: defining the rules of protein degradation
Zhang, Z., Mena, E. L., Timms, R. T., Koren, I., & Elledge, S. J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00870-z · Cited by 67
Sulforaphane Protects against Brain Diseases: Roles of Cytoprotective Enzymes
Zhang, F. (2017) · Austin Journal of Cerebrovascular Disease & Stroke · doi:10.26420/austinjcerebrovascdisstroke.2017.1054 · Cited by 53
NRF-2 and nonalcoholic fatty liver disease
Solano-Urrusquieta, A., Morales‐González, J. A., Castro‐Narro, G., Reyes, E. C., Flores-Rangel, P. D., & Fierros-Oceguera, R. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2019.11.010 · Cited by 54
Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
Song, J. H., Singh, N., Luevano, L. A., Padi, S. K. R., Okumura, K., Olive, V., Black, S. M., Warfel, N. A., Goodrich, D. W., & Kraft, A. S. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0374 · Cited by 52
Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane
Habtemariam, S. (2024) · Biomedicines · doi:10.3390/biomedicines12061169 · Cited by 54
Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics
Tong, Y., Zhang, B., Fan, Y., & Lin, N. (2015) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2015.09.002 · Cited by 51
Tan, M., Xu, J., Siddiqui, J., Feng, F. Y.-C., & Sun, Y. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0567-6 · Cited by 51
Neddylation regulation of mitochondrial structure and functions
Zhou, Q., Zheng, Y., & Sun, Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00569-6 · Cited by 51
Heme oxygenase-1-derived bilirubin protects endothelial cells against high glucose-induced damage
He, M., Nitti, M., Piras, S., Furfaro, A. L., Traverso, N., Pronzato, M. A., & Mann, G. E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.151 · Cited by 49
Yuan, J.-T., Yu, Z., Gao, J., Luo, K., Shen, X., Cui, B., & Lu, Z. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102224 · Cited by 50
Alexander, C., Parsaee, A., & Vasefi, M. (2023) · Biology · doi:10.3390/biology12111453 · Cited by 52
Keap1-independent Nrf2 regulation: A novel therapeutic target for treating kidney disease
Zhang, J., Zhang, M., Tatar, M., & Gong, R. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103593 · Cited by 58
Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease
Marchetti, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101664 · Cited by 52
Nakano-Kobayashi, A., Fukumoto, A., Morizane, A., Nguyen, D. T., Le, T. M., Hashida, K., Hosoya, T., Takahashi, R., Takahashi, J. B., Hori, O., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc1428 · Cited by 50
Activators of Nrf2 to Counteract Neurodegenerative Diseases
Amoroso, R., Maccallini, C., & Bellezza, I. (2023) · Antioxidants · doi:10.3390/antiox12030778 · Cited by 49
Das, B. N., Kim, Y. W., & Keum, Y. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/839409 · Cited by 49
Panieri, E., & Saso, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8146 · Cited by 46
Ji, L., Moghal, N., Zou, X., Fang, Y., Hu, S., Wang, Y., & Tsao, M. (2022) · Cancer Medicine · doi:10.1002/cam4.5311 · Cited by 46
Fronza, M. G., Alves, D. A. C., Praticò, D., & Savegnago, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102033 · Cited by 47
Bayele, H. K., Balesaria, S., & Srai, S. K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.001 · Cited by 47
Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression
Liu, D., Zhang, Y., Wei, Y., Liu, G., Liu, Y., Gao, Q., Zou, L., Zeng, W., & Zhang, N. (2016) · Oncotarget · doi:10.18632/oncotarget.11700 · Cited by 47
β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling
Long, M. J. C., Lin, H., Parvez, S., Zhao, Y., Poganik, J. R., Huang, P., & Aye, Y. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.06.009 · Cited by 45
The KEAP1-NRF2 System and Esophageal Cancer
Hirose, W., Oshikiri, H., Taguchi, K., & Yamamoto, M. P. (2022) · Cancers · doi:10.3390/cancers14194702 · Cited by 48
McMahon, M. J., Swift, S., & Hayes, J. D. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.033 · Cited by 46
Self-citationLiu, Y., Xu, X., Xu, R., & Zhang, S. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s213088 · Cited by 46
Significance of NRF2 in physiological and pathological conditions an comprehensive review
Kryszczuk, M., & Kowalczuk, O. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109417 · Cited by 44
Chen, M., Fang, Y., Ge, Y., Qiu, S., Dworkin, L. D., & Gong, R. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103127 · Cited by 48
The Nrf2-Keap1/ARE signaling pathway in aquatic animals
Bian, D., Zhang, X., Zhu, X.-R., Tang, W.-H., Qin, P., Chen, Y.-H., Wang, G., Zhang, D.-Z., Tang, B., & Liu, Q. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142595 · Cited by 48
Nrf2 as a master regulator of tissue damage control and disease tolerance to infection
Soares, M. P., & Ribeiro, A. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150054 · Cited by 46
Jiang, Z., Lu, M., & You, Q. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01121 · Cited by 45
Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP+-Induced Cell Damage
Armağan, G., Sevgili, E., Gürkan, F. T., Köse, F. A., Bilgiç, T., Dağcı, T., & Saso, L. (2019) · Molecules · doi:10.3390/molecules24071377 · Cited by 45
Rosa, P. L., Bertini, E., & Piemonte, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030916 · Cited by 45
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
Jiménez-Villegas, J., Ferraiuolo, L., Mead, R. J., Shaw, P. J., Cuadrado, A., & Rojo, A. I. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.022 · Cited by 44
Self-citationWalters, T. S., McIntosh, D., Ingram, S., Tillery, L., Motley, E. D., Arinze, I., & Misra, S. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000351 · Cited by 44
Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
Zhang, S., Duan, S., Xie, Z., Bao, W., Xu, B., Yang, W., & Zhou, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924817 · Cited by 50
Tobón-Velasco, J. C., Vázquez‐Victorio, G., Macías‐Silva, M., Cuevas, E., Ali, S. F., Maldonado, P. D., González-Trujano, M. E., Cuadrado, A., Pedraza‐Chaverrí, J., & Santamarı́a, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.040 · Cited by 44
Self-citationRetractedChoe, K. P., Leung, C. K., & Miyamoto, M. M. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.684799 · Cited by 47
Kitakaze, T., Makiyama, A., Samukawa, Y., Jiang, S., Yamashita, Y., & Ashida, H. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.012 · Cited by 44
Non-covalent NRF2 Activation Confers Greater Cellular Protection than Covalent Activation
Liu, P., Tian, W., Tao, S., Tillotson, J., Wijeratne, E. M. K., Gunatilaka, A. A. L., Zhang, D. D., & Chapman, E. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.07.011 · Cited by 47
ER-Resident Transcription Factor Nrf1 Regulates Proteasome Expression and Beyond
Hamazaki, J., & Murata, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103683 · Cited by 44
Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
Panda, H., Wen, H., Suzuki, M., & Yamamoto, M. P. (2022) · Antioxidants · doi:10.3390/antiox11030538 · Cited by 46
Nrf2: A promising therapeutic target in bone-related diseases
Che, J., Yang, X., Jin, Z., & Xu, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115748 · Cited by 45
The scaffold protein AXIN1: gene ontology, signal network, and physiological function
Qiu, L., Sun, Y., Ning, H., Chen, G., Zhao, W., & Gao, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01482-4 · Cited by 43
Li, X., Chatterjee, N., Spirohn, K., Boutros, M., & Bohmann, D. (2016) · Scientific Reports · doi:10.1038/srep21455 · Cited by 44
Kim, J. H., Xu, E. Y., Sacks, D. B., Lee, J. H., Shu, L., Xia, B., & Kong, A. T. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4586 · Cited by 42
Eggler, A. L., & Savinov, S. N. (2013) · Springer eBooks · doi:10.1007/978-3-319-00581-2_7 · Cited by 42
Proteome Stability as a Key Factor of Genome Integrity
Gumeni, S., Evangelakou, Z., Gorgoulis, V. G., & Trougakos, I. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102036 · Cited by 44
Yang, Y., Ding, Z., Zhong, R., Xia, T., Wang, W., Zhao, H. L., Wang, Y., & Shu, Z. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.063 · Cited by 42
Michalska, P., Mayo, P., Fernández‐Mendívil, C., Tenti, G., Duarte, P., Buendía, I., Ramos, M. T., López, M. G., Menéndez, J. C., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080650 · Cited by 42
KEAP1/NRF2 (NFE2L2) mutations in NSCLC – Fuel for a superresistant phenotype?
Dempke, W. C. M., & Reck, M. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.07.006 · Cited by 43
Exercise-induced Nrf2 activation increases antioxidant defenses in skeletal muscles
Powers, S. K., Lategan-Potgieter, R., & Goldstein, E. R. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.07.041 · Cited by 45
Padmavathi, G., & Ramkumar, K. M. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108725 · Cited by 40
CRYPTOCHROMES confer robustness, not rhythmicity, to circadian timekeeping
Putker, M., Wong, D., Seinkmane, E., Rzechorzek, N. M., Zeng, A., Hoyle, N. P., Chesham, J. E., Edwards, M. D., Feeney, K. A., Fischer, R., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106745 · Cited by 40
Hushpulian, D. M., Kaidery, N. A., Ahuja, M., Poloznikov, A. A., Sharma, S. M., Gazaryan, I. G., & Thomas, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.673205 · Cited by 41
Wang, Y., Zhang, X., Meng, F.-G., & Zeng, T. (2021) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2021.1894624 · Cited by 40
Seminotti, B., Grings, M., Tucci, P., Leipnitz, G., & Saso, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.785057 · Cited by 45
Feng, J., Read, O. J., & Dinkova‐Kostova, A. T. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2183 · Cited by 42
Role of NRF2 in Pathogenesis of Alzheimer’s Disease
Chu, C., Uruno, A., Katsuoka, F., & Yamamoto, M. (2024) · Antioxidants · doi:10.3390/antiox13121529 · Cited by 43
The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance
Choi, B.-H., Kim, J. M., & Kwak, M. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01316-8 · Cited by 40
Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
Rysz, J., Franczyk, B., Rysz-Górzyńska, M., & Gluba-Brzózka, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010183 · Cited by 41
Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma
Chen, J., Yu, Y.-J., Ji, T., Ma, R., Chen, M., Li, G.-F., Li, F.-B., Ding, Q., Kang, Q., Huang, D.-Y., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.788 · Cited by 34
Gao, X., Jiang, S., Du, Z., Ke, A., Liang, Q., & Li, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8564681 · Cited by 39
Haque, E., Karim, M. R., Teeli, A. S., Śmiech, M., Leszczyński, P., Winiarczyk, D., Parvanov, E. D., Atanasov, A. G., & Taniguchi, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155378 · Cited by 40
Ghosh, S., Dutta, N., Banerjee, P., Gajbhiye, R. L., SARENG, H. R., Kapse, P., Pal, S., Burdelya, L. G., Mandal, N. C., Ravichandiran, V., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.037 · Cited by 36
Role of chemopreventive phytochemicals in NRF2-mediated redox homeostasis in humans
Chun, K., Raut, P. K., Kim, D., & Surh, Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.031 · Cited by 37
Zhu, X., Zhang, Y., Zhang, M., Chen, Y.-J., & Liu, Y. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00785-6 · Cited by 39
Srivastava, R., Fernández-Ginés, R., Encinar, J. A., Cuadrado, A., & Wells, G. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.023 · Cited by 41
Self-citationKhassafi, N., Tameh, A. A., Mirzaei, H., Rafat, A., Barati, S., Khassafi, N., & Vahidinia, Z. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114655 · Cited by 38
Lee, H., Park, Y. H., Jeon, Y.-T., Hwang, J., Lim, Y., Kim, E., Park, S. Y., & Park, H. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu268 · Cited by 38
Targeting Protein Quality Control Mechanisms by Natural Products to Promote Healthy Ageing
Wedel, S., Manola, M. S., Cavinato, M. S., Trougakos, I. P., & Jansen‐Dürr, P. (2018) · Molecules · doi:10.3390/molecules23051219 · Cited by 39
Sahoo, B. R., Crook, A. A., Pattnaik, A., Torres-Gerena, A. D., Khalimonchuk, O., Powers, R., Franco, R., & Pattnaik, A. K. (2023) · Journal of Virology · doi:10.1128/jvi.01363-22 · Cited by 37
Glycogen Synthase Kinase 3β Influences Injury Following Cerebral Ischemia/Reperfusion in Rats
Li, Y., Zhu, J. X., Liu, Y., Chen, X., Lei, S., Li, L., Jiang, B., Tan, L. H., Yu, S., & Zhao, Y. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.13918 · Cited by 37
Alterations in System xc− Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2
Carpi-Santos, R., & Calaza, K. D. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0961-8 · Cited by 38
Peng, S., Hou, Y., Yao, J., & Fang, J. (2019) · BioFactors · doi:10.1002/biof.1488 · Cited by 37
Zhou, Y., Wang, K., Zhou, Y., Li, T., Yang, M., Wang, R., Chen, Y., Cao, M., & Hu, R. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101390 · Cited by 38
Escoll, M., Lastra, D., Pajares, M., Robledinos-Antón, N., Rojo, A. I., Fernández-Ginés, R., Mendiola, M., Martínez-Marín, V., Esteban, I., López‐Larrubia, P., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101425 · Cited by 37
Self-citationSilvestro, S., & Mazzon, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010199 · Cited by 36
Xie, C., Wei, D., Zhao, L., Marchetto, S., Mei, L., Borg, J., & Sun, Y. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201411104 · Cited by 38
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
Lima, K. A., Osawa, I. Y. A., Ramalho, M. C. C., de Souza, I., Guedes, C. B., Filho, C. H. D. D. S., Monteiro, L. K. S., Latância, M. T., & Rocha, C. R. R. (2023) · Biomedicines · doi:10.3390/biomedicines11041081 · Cited by 41
NRF2 in neurodegenerative diseases
Cuadrado, A. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.004 · Cited by 36
Self-citationWang, S., & Qi, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.916653 · Cited by 39
Targeting Nrf2 and NF-κB Signaling Pathways in Cancer Prevention: The Role of Apple Phytochemicals
Gado, F., Ferrario, G., Vedova, L. D., Zoanni, B., Altomare, A., Carini, M., Aldini, G., D’Amato, A., & Baron, G. (2023) · Molecules · doi:10.3390/molecules28031356 · Cited by 35
Ebrahimi, K. B., Cano, M., Rhee, J., Datta, S., Wang, L., & Handa, J. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7084 · Cited by 35
Li, L., Tian, X., Peng, W., Deng, Y., & Li, J. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.265564 · Cited by 34
The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy
Miller, W. P., Sunilkumar, S., & Dennis, M. D. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.041 · Cited by 35
Siswanto, F. M., Sakuma, R., Oguro, A., & Imaoka, S. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac062 · Cited by 34
Dinkova‐Kostova, A. T. (2012) · Scientifica · doi:10.6064/2012/606104 · Cited by 36
Metadata
- Authors
- Rada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- University of Dundee (GB)
- Corresponding author
- Cuadrado, Antonio
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-03-01
- Volume
- 31
- Issue
- 6
- Pages
- 1121-1133
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3067901
- OpenAlex
- W2118394016
- Cited by
- 759
- References
- 55
- Citations by year
- 2026: 40 · 2025: 36 · 2024: 53 · 2023: 76 · 2022: 60 · 2021: 71 · 2020: 80 · 2019: 50 · 2018: 47 · 2017: 59 · 2016: 49 · 2015: 51 · 2014: 27 · 2013: 27 · 2012: 21
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Nrf2, glycogen synthase kinase-3, β-TrCP, protein degradation, serine phosphorylation, ubiquitination, transcription factor regulation, redox signaling
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Kelch-Like ECH-Associated Protein 1, Amino Acid Sequence, Animals, Cell Line, Cytoskeletal Proteins, Humans, Molecular Sequence Data, Mutation, Phosphorylation, Serine, Protein Structure, Tertiary, Glycogen Synthase Kinase 3, Ubiquitin-Protein Ligases, beta-Transducin Repeat-Containing Proteins, Adaptor Proteins, Signal Transducing, NF-E2-Related Factor 2, Mice, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review